DIANE OLIVER: Open Payments
NPI 1164881546 · YOUNGSTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,420 in 126 payments from 15 companies in 2025. Trend: 2023 $863 · 2024 $1,194 · 2025 $2,420
Food & beverage: $2,420
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $324 |
| Teva Pharmaceuticals USA, Inc. | 20 | $318 |
| ABBVIE INC. | 17 | $298 |
| E.R. Squibb & Sons, L.L.C. | 9 | $294 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $256 |
| Otsuka America Pharmaceutical, Inc. | 10 | $195 |
| Lundbeck LLC | 13 | $190 |
| Janssen Pharmaceuticals, Inc | 7 | $165 |
| Alkermes, Inc. | 5 | $120 |
| Neurocrine BioSciences, Inc. | 6 | $96 |
Products named: CAPLYTA, VRAYLAR, COBENFY, ABILIFY MAINTENA, TRINTELLIX, AUSTEDO XR, INVEGA SUSTENNA, ARISTADA.
Industry payments across OH — which companies pay providers there.
